- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-squamous, Non-Small Cell Lung Cancer in Colombia
Total 752 results
-
Atreca, Inc.TerminatedMelanoma | Breast Cancer | Hepatocellular Carcinoma | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Urothelial Carcinoma | Acral Lentiginous Melanoma | Platinum-Resistant Fallopian... and other conditionsUnited States
-
University of Maryland, BaltimoreCompletedHead and Neck Cancer | Oropharyngeal Squamous Cell Carcinoma | Oropharynx CancerUnited States
-
Gemin XCephalonCompletedExtensive-stage Small Cell Lung CancerCanada, United States, United Kingdom, Serbia, Bulgaria, India, Hungary, Czech Republic, Poland, Romania
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell LungItaly, Netherlands, Argentina, Brazil, China, Denmark, Greece, Panama, Spain, United Arab Emirates, United Kingdom, Mexico, Poland, Peru, Philippines, Costa Rica, Malaysia, Morocco, Latvia, Lebanon, Sweden, Slovenia, Colombia, Guatemala
-
Sunesis PharmaceuticalsCompletedSmall Cell Lung Cancer | Carcinoma, Small CellUnited States, Canada
-
Genzyme, a Sanofi CompanyCompleted
-
AstraZenecaCompletedCarcinoma, Non-Small-Cell LungUnited States, Canada, Denmark, France, Netherlands, Belgium, Poland, Taiwan, Thailand, Vietnam, Italy, Korea, Republic of, Brazil, Czechia, Hungary, Japan, Russian Federation, Germany, Hong Kong, Spain, Greece, Switzerland, Australia, Isra... and more
-
AmgenRecruitingSmall Cell Lung Cancer (SCLC)China, United States, Australia, Netherlands, Taiwan, Spain, Canada, Korea, Republic of, Turkey, Israel, Austria, Japan, France, United Kingdom, Germany, Belgium, Denmark, Czechia, Switzerland, Italy, Hungary, Ireland, Argentina, Brazil, Malays... and more
-
ImmunoGen, Inc.CompletedSmall Cell Lung CancerUnited States
-
Janssen Research & Development, LLCActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, France, Canada, China, Israel, Belgium, United Kingdom, Italy, Argentina, Japan, Taiwan, Thailand, Korea, Republic of, Malaysia, Poland, Australia, Spain, Netherlands, Hungary, Turkey, Germany, India, Brazil, Russian Federation and more
-
Janssen Research & Development, LLCActive, not recruitingCarcinoma, Non-Small-Cell LungCanada, Germany, Italy, China, Belgium, United States, Taiwan, Israel, United Kingdom, Korea, Republic of, Sweden, Japan, Poland, Malaysia, Netherlands, Spain, Turkey, France, India, Mexico, Argentina, Brazil, Portugal, Russian Federation and more
-
Janssen Research & Development, LLCActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Canada, Germany, Japan, China, Israel, Belgium, Italy, France, Taiwan, Thailand, Korea, Republic of, Malaysia, Spain, Hungary, Turkey, Portugal, India, Brazil, Poland, Australia, Russian Federation, Mexico, Puerto Rico, U... and more
-
Hoffmann-La RocheActive, not recruitingNSCLCBelgium, Australia, China, Croatia, Finland, Turkey, Italy, Israel, Serbia, Austria, Romania, Peru, Lithuania, Colombia, Portugal, Czechia, Cuba, Russian Federation, Bulgaria, Vietnam, Uruguay, United Arab Emirates, Argentina, Chile, Pa...
-
National Cancer Institute (NCI)RecruitingExtensive Stage Lung Small Cell Carcinoma | Limited Stage Lung Small Cell Carcinoma | Platinum-Resistant Lung Small Cell Carcinoma | Platinum-Sensitive Lung Small Cell Carcinoma | Recurrent Lung Small Cell CarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell LungUnited States, Spain, France, Belgium, Australia, Germany, Argentina, Japan, Brazil, Italy, Singapore, Russian Federation, Taiwan, Netherlands, Peru, Chile, Latvia, Ukraine, Mexico, Lithuania, Slovakia, Bulgaria, Portugal, Austria, Swit... and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Merck Sharp & Dohme LLCRecruitingCarcinoma, Non-Small-Cell LungPoland, United States, Hungary, Israel, Italy, Korea, Republic of, Spain
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, United States, Hungary, Israel, Italy, Korea, Republic of, Spain
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, United States, Hungary, Israel, Italy, Korea, Republic of, Spain
-
GenmabCompletedHead and Neck Cancer | Squamous Cell CancerUnited States, Germany, Israel, Colombia, Czechia, Austria, Chile, Italy, Peru, Portugal, Slovakia
-
ImmunoGen, Inc.TerminatedSmall Cell Lung CancerUnited States, Spain, Canada, United Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, United States, Hungary, Israel, Italy, Korea, Republic of, Spain
-
Puma Biotechnology, Inc.RecruitingSmall Cell Lung CancerUnited States
-
Hospital Departamental de VillavicencioCooperative University of ColombiaRecruitingCancer | Chronic Disease | Public Health | Hospital Mortality | Non Communicable Chronic DiseasesColombia
-
AstraZenecaRecruitingCervical Cancer | Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Biliary Cancer | Additional Indications Below for Module 4 and 5 | Small Cell Lung Cancer Only in Module 5Canada, Spain, China, Korea, Republic of, Italy, Poland, United States, Australia, United Kingdom, Japan, Hungary, Russian Federation, Czechia
-
NRG OncologyNational Cancer Institute (NCI)RecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Lung Small Cell Carcinoma | Recurrent Lung Small Cell CarcinomaUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Ascenta TherapeuticsCompletedSmall Cell Lung CancerUnited States, Russian Federation, Ukraine
-
AstraZenecaParexelActive, not recruitingRelapsed or Refractory B-cell Non-Hodgkin LymphomaUnited States, Korea, Republic of, Canada, United Kingdom, Spain, France, Denmark
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingNon-Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Any Solid TumorUnited States, Japan, Taiwan, Australia, Korea, Republic of, Israel, Spain, Switzerland, Singapore, France, Canada, Italy, Germany, United Kingdom, Hong Kong, Denmark
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaUnited States
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Chronic Lymphocytic LeukemiaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
National Baromedical ServicesMayo Clinic; Dartmouth-Hitchcock Medical Center; CISSS de Chaudière-Appalaches; Memorial Hermann Hospital and other collaboratorsNot yet recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, Canada
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Stage IIA Cervical Cancer AJCC v7 | Stage IB Cervical Cancer AJCC v6 and v7 | Stage I Cervical Cancer AJCC v6 and v7 | Stage IA Cervical Cancer AJCC v6 and v7United States, Korea, Republic of, Japan
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
OncoC4, Inc.National Cancer Institute (NCI)RecruitingCervical Cancer | Small Cell Lung Cancer | Adenoid Cystic Carcinoma | Metastatic Renal Cell Carcinoma | Metastatic Colorectal Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Metastatic Melanoma | Pancreas Cancer | Metastatic... and other conditionsUnited States, Australia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung CancerUnited States, Canada, Puerto Rico
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedLung CancerUnited States, Canada
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungGermany, Canada, United States, Hong Kong, Taiwan, Brazil, Korea, Republic of, Peru, Poland, Ukraine, Thailand, Argentina, Australia, New Zealand, Sweden, Hungary, Turkey, Serbia, Bosnia and Herzegovina, Chile, Colombia, Ecuador, Ir... and more
-
Gustave Roussy, Cancer Campus, Grand ParisEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedLung CancerKorea, Republic of, France, Switzerland, Greece, Spain, Israel, Portugal, United Kingdom, Belgium, Netherlands, United States, Italy, Germany, Serbia, Chile, Turkey, Japan, South Africa, Poland, Australia, Romania, Colombia, Macedonia... and more
-
Merck Sharp & Dohme LLCCompletedCarcinoma, Non-Small-Cell LungUnited States, Ireland, Argentina, Australia, Brazil, Canada, Chile, Colombia, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Peru, Poland, South Africa, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kingdom
-
Juno Therapeutics, a Subsidiary of CelgeneCompletedLymphoma Non-Hodgkin | Agressive Lymphoma | Diffuse-large B-cell Lymphoma (DLBCL)United States, Canada
-
National Cancer Institute (NCI)RecruitingHIV Infection | Anal Squamous Cell Carcinoma | Anal Canal Cloacogenic Carcinoma | Stage III Anal Cancer AJCC v8 | Stage III Rectal Cancer AJCC v8 | Stage II Rectal Cancer AJCC v8 | Anal Margin Squamous Cell Carcinoma | AIDS-Related Anal Carcinoma | Rectal Squamous Cell Carcinoma | Stage I Anal Cancer AJCC... and other conditionsUnited States
-
Eli Lilly and CompanyCompletedSmall Cell Lung CancerSpain, United States, Germany, Ukraine, France, Greece, Turkey, Netherlands, United Kingdom, Korea, Republic of
-
Merck Sharp & Dohme LLCGilead SciencesRecruitingCarcinoma, Non-Small-Cell LungChina, Poland, Latvia, United States, Taiwan, Australia, Turkey, Germany, Israel, Korea, Republic of, Estonia, Romania, Chile, Italy, Brazil, Greece, Philippines, Canada, Japan, Malaysia, United Kingdom, Lithuania, Thailand, Peru
-
xCuresCancer CommonsAvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesMelanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditionsUnited States
-
CelgeneCompletedSmall Cell Lung CancerUnited States, Netherlands, United Kingdom
-
PfizerTerminatedSmall Cell Lung CarcinomaUnited States, Spain, Canada, Hungary